Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO ...

Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular ...
Healio

Expert panel assesses visual function tests for use in diabetic retinal disease staging

Please provide your email address to receive an email when new articles are posted on . Best corrected visual acuity was the only visual function test ready for use in a diabetic retinal disease ...
The Manila Times

Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases

The data highlight emerging evidence that Opus Genetics’ gene therapy OPGx-LCA5 may restore daytime vision mediated by cones ...
Healio

Mobile apps, with proper validation, can accurately perform visual function tests

Please provide your email address to receive an email when new articles are posted on . Mobile apps can successfully mimic paper-based visual function tests, results showed. Such apps may expand ...